Evelyn Harrison
Direttore Tecnico/Scientifico/R&S presso IVERIC BIO, INC.
Profilo
Evelyn M.
Harrison is currently the Chief Clinical Operations Officer & Senior VP at IVERIC bio, Inc. She previously worked as the Director-Clinical Operations at Hoffmann-La Roche, Inc. from 1990 to 2000 and as the SVP-Clinical Research & Development at Oldtech, Inc. in 2006.
She completed her undergraduate degree at Hofstra University and holds an MBA from Manhattan College.
Posizioni attive di Evelyn Harrison
| Società | Posizione | Inizio |
|---|---|---|
| IVERIC BIO, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2017 |
Precedenti posizioni note di Evelyn Harrison
| Società | Posizione | Fine |
|---|---|---|
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Direttore Tecnico/Scientifico/R&S | 01/01/2006 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/01/2000 |
Formazione di Evelyn Harrison
| Hofstra University | Undergraduate Degree |
| Manhattan College | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Borsa valori
- Insiders
- Evelyn Harrison
